ReviewParasites & vectors2026
Revisiting Leishmania (Viannia) lainsoni Silveira, Shaw, Braga, and Ishikawa, 1987: current knowledge and emerging perspectives.
Review in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
More than three decades after its description, Leishmania (Viannia) lainsoni Silveira, Shaw, Braga, and Ishikawa, 1987 remains the least explored species of the subgenus Viannia Lainson and Shaw, 1987 within the genus Leishmania Ross, 1903. Although long considered rare and of limited clinical impact, recent records reveal a wider geographic range, diverse vector associations, and increasing involvement in American cutaneous leishmaniasis (ACL). Advances in molecular and genomic studies have clarified its taxonomy and uncovered notable biological and genetic variability. This review synthesizes current knowledge on the distribution, vectors, reservoirs, pathogenicity, and clinical relevance of L. (V.) lainsoni, highlighting emerging evidence that challenges earlier assumptions and emphasizing key research gaps for improving surveillance and understanding of its transmission dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.